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Virus lasers for biological detection
John E. Hales 1, Guy Matmon 2, Paul A. Dalby 1, John M. Ward 1 & Gabriel Aeppli2,3,4
The selective ampliﬁcation of DNA in the polymerase chain reaction is used to exponentially
increase the signal in molecular diagnostics for nucleic acids, but there are no analogous
techniques for signal enhancement in clinical tests for proteins or cells. Instead, the signal
from afﬁnity-based measurements of these biomolecules depends linearly on the probe
concentration. Substituting antibody-based probes tagged for ﬂuorescent quantiﬁcation with
lasing detection probes would create a new platform for biomarker quantiﬁcation based on
optical rather than enzymatic ampliﬁcation. Here, we construct a virus laser which bridges
synthetic biology and laser physics, and demonstrate virus-lasing probes for biosensing. Our
virus-lasing probes display an unprecedented > 10,000 times increase in signal from only a
50% increase in probe concentration, using ﬂuorimeter-compatible optics, and can detect
biomolecules at sub-100 fmol mL−1 concentrations.
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Antibody-based probes tagged for ﬂuorescent quantiﬁca-tion can bind a wide range of biomolecular targets withhigh speciﬁcity, but generate a weak signal, which can be
difﬁcult to distinguish from background noise.1 Lasing detection
probes would be a superior alternative, as they would generate
intense, monochromatic signals and the onset of lasing would
coincide with a sharp increase in the radiant energy in a
resonator-dependent emission line.2–5 However, no new detec-
tion probes have been developed which can both harness lasing
and also bind a broad range of epitopes with the speciﬁcity of
antibodies, despite the construction of lasers from biological
components such as DNA scaffolds and ﬂuorescent-protein-
expressing cells,6–24 and the synthesis of plasmonic
nanolasers.25,26
Biolasers, in which biological components form part of the
lasing medium, offer greater potential for biocompatibility than
plasmonic nanolasers, which are interesting and complex metallic
systems.25,26 Dye-labelled antibodies themselves are not ideal
candidates because they can only typically be conjugated with up
to four dyes per antibody before the degree of labelling interferes
with target binding and the yield of the dyes.27 By contrast,
ﬁlamentous bacteriophage M13—a 7 nm × 900 nm rod-like virus
that infects F pilus expressing strains of E. coli28,29—has been
used effectively as a substitute for antibody probes in cell imaging,
ﬂow cytometry and enzyme-linked immunosorbent assays
(ELISA)30,31 and as the key component in nanosystems
such as virus-based lithium-ion batteries and piezoelectric gen-
erators.32–34 Using phage display, M13 can be routinely pro-
grammed to bind speciﬁc target biomolecules either by display of
known antibody domains or binding proteins fused to either the
gene 3 or 8 coat proteins, or by selection from phage-displayed
combinatorial libraries to isolate those with the required target-
binding speciﬁcity and afﬁnity.30,32,33,35–38 Phage surfaces can be
functionalised by coupling amine-reactive dyes to α-amines at
Ala1 and ε-amines at Lys8 on the 2700 50 amino-acid alpha-
helical gene 8 coat proteins, or to solvent-exposed primary
amines on the ﬁve gene 3 coat proteins.28,29 The gene 8 coat
proteins form an overlapping quasicrystalline lattice with a 5-fold
rotation axis and a two-fold screw axis,39 which brings the dyes
into close proximity—much smaller than the wavelength of
visible light—enabling electronic interactions and leading to
resonant energy transfer between dye molecules as well as
ﬂuorescence quenching (Fig. 1a).40–42
Here, we create a virus laser from ﬂuorescein-dye-labelled
M13 and demonstrate its capabilities as an analytical platform
for ligand-binding assays. Dye-labelled phage-clones derived
from phage-display are already known to maintain their target-
binding capability after selective labelling, and so these probes
can replace dye-conjugated primary antibodies in biological
assays.31 We show that probes of this type can be used as virus-
lasing media to generate a lasing signal in an optical conﬁg-
uration compatible with ordinary ﬂuorimeters, and also to
detect the binding of a target antibody molecule. The structural
order and repeating chemical landscape on the surface of M13
provide a versatile and amenable model system for modulating
the spectrum and threshold dynamics of the laser using the
principles of synthetic biology. At the transition to lasing, the
photon ﬂux from the probes increases by ﬁve orders of mag-
nitude, the spectral linewidth narrows to below 5.0 nm, and
the sensitivity of the output intensity to small changes in the
probe concentration or environment is heightened. We show
that a 50% increase in the concentration of the probes from
100 pmol mL−1 results in a >10,000 times increase in signal,
which is the greatest responsivity to probe concentration
shown in any biochemical assay to the best of our knowledge.
In a proof-of-concept study, we optically engineer a mix-and-
measure ligand-binding assay sensitive to 90 fmol mL−1
monoclonal antibody, suggesting that clinically relevant con-
centrations of biomolecules can be detected without immobili-
zation of the ligand or probe on surfaces and without invasive
wash steps.
Results
Virus lasers as an analytical platform. We examined the prop-
erties of virus lasers in which the gain medium is a solution of
ﬂuorescein-dye-labelled M13 in two contrasting resonator geo-
metries. Resonant cavity R1 was constructed to explore virus-
lasing for metrology (Supplementary Fig. 1), and resonant cavity
R2 was engineered to strengthen the coupling of the virus-lasing
to the near-ﬁeld and electronic interactions of the dyes (Fig. 1b,
Supplementary Fig. 1). In both instruments, the excitation and
detection optics were similar to those in a ﬂuorimeter, except for
the greater than eight-decade dynamic range of the spectrometer
and the intensity of the 3–5 ns excitation pulses at 493 nm
(Fig. 1b; details in Methods). The gain medium was circulated
between a reservoir and a ﬂow cuvette and the pump light source
operated in single-shot mode to allow the dye to be refreshed
between pulses (Fig. 1b).
R1 consisted of a ﬂat mirror separated by 300 mm from a
spherical mirror with a radius of curvature of 400 mm, equivalent
to 2 round-trips per FWHM (full width at half maximum) of the
temporal proﬁle of the pump laser pulse. The diameter of the
beam was constrained only by the 2 mm × 2mm windows of
the cuvette. In contrast to microresonators, these dimensions are
much greater than microbiological length scales ensuring that
there was no mechanical interference from the resonator.
In Fig. 2a, we display a series of threshold curves demonstrat-
ing laser action for different probe concentrations as well as for
ﬂuorescein in solution with no virus. For the highest probe
concentration (purple), 413 pmol mL−1 M13 conjugated with 386
dyes per M13 (V1)— equivalent to 0.7 dyes on average per ring of
proteins—doubling the pump energy from below to above the
threshold point for lasing, increased the intensity at the spectral
peak by a factor of 16,000 (Fig. 2a).
We have measured the threshold region of the virus laser with
unprecedented precision across 7 decades of intensity because it is
this non-linearity that makes lasing such a unique analytical
prospect. Data for other biolasers have typically been restricted to
1–2 decades of dynamic range6–9,11–13,15–24 (Supplementary
Fig. 3) and quite often, only the above-threshold region was
measured,6,11,13–17,19–24 meaning that the position of the thresh-
old point could only be found from linear extrapolation, reducing
the potential utility of these biolasers as analytical instruments. In
Fig. 2a, the initial deviations in intensity from sub-threshold
behaviour are due to the ampliﬁcation of seed ﬂuorescence before
the gain can overcome the resonator losses, and the inﬂection
points are the transitions to lasing.
The threshold for 146 nmol mL−1 ﬂuorescein (F1, dark orange)
was 2.2 times lower than for 351 pmol mL−1 V1 (dark blue),
which had a similar volume-averaged optical density equivalent
to 135 nmol mL−1 ﬂuorescein. This implies that there was
enhanced quenching of the dyes attached to M13 due to dye–dye
or dye–protein interactions, since the lasing threshold φth varies
according to
φth ¼
K2 KL
KF D KRAD  KLð Þ
ð1Þ
This equation is derived in the Theoretical models section of the
Methods. The microenvironments provided by the virus and
solvent for the dyes will affect the decay rate K2 from the upper
state of the dye, but optical absorption data show no inﬂuence on
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the strength KF of the coupling of the pump to the dyes
(Supplementary Fig. 2). If the resonator, deﬁned by the loss rate
KL, the rate KRAD of spontaneous emission per dye into the
resonator mode and the number D of dyes in the mode volume
are unchanged and D is large, the ratio of ultimate lasing output
energy n to pump power φ will be the same for V1 and F1
because in the high power limit
n
φ
! β KF
KRAD
D KRAD
KL
 1
 
! β KFD
KL
ð2Þ
where β is the optical attenuation due to the output coupler and
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Fig. 1 Design of the virus laser. a Model of the atomic structure of a lasing detection probe composed of M13 bacteriophage (PDB: 2MJZ) covalently
modiﬁed with ﬂuorescein isothiocyanate isomer 1 (FITC) dyes (PubChem CID: 18730, green).29,57,58 There are ~540 rings of gene 8 coat proteins per M13,
but only 13 are shown here. The target biomolecule is a IgG2a monoclonal antibody (mAb) that can be bound by the gene 3 coat proteins and is
represented in the ﬁgure by the structure of an intact IgG2a mAb (PDB: 1IGT) which should have a homologous structure.59 Rectangular zoomed area,
image of the surface of M13 showing the close proximity of the attached dyes. Circular zoomed area, chemical structure of ﬂuorescein isothiocyanate.
Fluorescein has shorter moieties bonded to the aromatic ring system than other xanthene dyes, such as rhodamine 6G, reducing the likelihood of contact
quenching between neighbouring dyes. b Optical conﬁguration for experiments conducted using resonant cavity R2 (Supplementary Fig. 1). The excitation
source was an optical parametric oscillator (OPO), the detector was a photomultiplier tube (PMT) and the emission was attenuated by neutral density
(ND) ﬁlters. Inset, photograph of the emission from the gain medium of the virus laser (green light) as viewed from along the axis of the resonator
100
1014 1015
Pump [photons pulse–1]
Pump [J pulse–1]
1016 520 530 540 550
Wavelength [nm]
560 570
100
101
102
103
104
105
ba
107
106
105
104
103
102
101
515 525 535 545
101
102
103
104
In
te
ns
ity
 [a
rb.
 
u
n
its
]
In
te
ns
ity
 [a
rb.
 
u
n
its
]
105
106
107
108
10–5 10–4 10–3 10–2
Fig. 2 Virus lasers. a Threshold behaviour in R1 for 146 nmol mL−1 ﬂuorescein (F1, dark orange) and for virus-lasing probes (V1) diluted from 413 pmol mL−1
(purple) to 351 pmol mL−1 (dark blue, equivalent to 135 nmol mL−1 ﬂuorescein), 270 pmol mL−1 (green), 219 pmol mL−1 (light purple), 185 pmol mL−1
(cyan), 140 pmol mL−1 (light green), 103 pmol mL−1 (blue), and 72 pmol mL−1 (grey). The ﬁtted curves represent a global ﬁt of all of the sets of threshold
data to a theoretical model (Supplementary Fig. 5; Methods). Errors in the concentration described in Methods. b Emission spectra of V1 at 413 pmol mL−1
as pumping increased from 5.5 × 1014 photons pulse−1 ± 10.1% (cyan) to 9.1 × 1014 photons pulse−1 ± 6.6% (dark blue). Inset, bathochromic shift in the
spectrum of V1 (purple, pumping of 1.5 × 1015 photons pulse−1 ± 10.9%) relative to 72 nmol mL−1 ﬂuorescein (orange, 1.7 × 1016 photons pulse−1 ± 11.4%).
Curves are ﬁts to the sum of two Gaussian peak functions. The intensity was not calibrated but was proportional to the number of photons entering the
spectrometer (see Methods). Source data are provided as a Source Data ﬁle
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the spectral bandwidth of the spectrometer (equations derived in
Methods). The data in Fig. 2a are consistent with equation (2).
The curves in Fig. 2a were derived from a model of the
threshold dynamics that describes the energy build-up in
the dominant mode in terms of the pump energy and the dye
concentration while accounting for the seed ﬂuorescence (see
Methods). We ﬁt the data globally with shared parameters for
experimental variables retained between measurements, such as
the number of resonator modes, and ﬁxed values for variables
which could be calculated in advance, including the rate of loss
from the resonator. From this model and by noting that from
equation (1) the threshold point is proportional to DDmin  1
 1
where Dmin ¼ KLKRAD, we estimate that the minimum number of
probes required for lasing is 93.4 pmol mL−1 ± 0.7 pmol mL−1,
which is approximately three orders of magnitude lower than the
lowest reported DNA Förster resonance energy transfer (FRET)
laser probe concentration.24 This value is at the upper limit of the
useful range for probes in a clinical context, but it could be
reduced straightforwardly by decreasing KL and/or increasing
KRAD via steps such as minimising Fresnel reﬂections at the
cuvette side-walls and shortening the resonant cavity.
Spectral linewidth narrowing has not been shown for a
solution-state biolaser previously and even here the spectral
measurement below threshold has been hampered by low light
levels. Even so, Fig. 2b demonstrates that the sharp rise in intensity
at threshold coincided with a change in the spectral line-shape
and a narrowing of the spectral linewidth to 4.0 nm ± 0.3 nm
(FWHM) above threshold at a pump energy of 9.1 × 1014 photons
pulse−1 ± 6.6%.
Unlike for a DNA FRET laser or a green ﬂuorescent protein
cell laser, the biological structural order of M13 impacts the
spectroscopic characteristics of a homogeneous ensemble of
chromophores in the virus laser. Moving the dyes closer together
ﬁrst by increasing the density in solution and then via
immobilization on the viruses red-shifted the spectral peak from
523.4 nm ± 0.2 nm for 72 nmol mL−1 ﬂuorescein (mean separa-
tion 28.5 nm) to 527.2 nm ± 0.4 nm for 301 nmol mL−1 ﬂuor-
escein (17.7 nm) to 529.6 nm ± 0.2 nm for V1 (Fig. 2b inset,
Supplementary Fig. 4). Thus, lasing viruses are analogous to
genetically-programmable quantum dots whose spectral peak
emission can be tuned not by varying their size but by varying the
number of dyes attached per virus.
Figure 3a and b show that the concentration of dye-labelled
M13 probes can be determined from the position of the threshold
point. We derived a simple function that can model threshold
data without requiring precise knowledge of the experimental
variables, and in Fig. 3a we implement this function (equation
(26) in Methods) to calculate the threshold points as a function of
the probe concentration (dark blue), and in matching units for
freely-dissolved ﬂuorescein (dark orange) (see Supplementary
Fig. 6 for individual ﬁts). The data points are in excellent
agreement with the cyan curve, which is the expected threshold
point position based on the global model of the threshold
dynamics (see Fig. 2a), proving that each set of threshold data
contained enough information to allow the probe concentration
to be calculated precisely.
Typically, threshold data are plotted as the intensity against
pump energy at constant dye concentration, as is the case in
Fig. 2a, but in Fig. 3b we show that the same data can be plotted
as the intensity against probe concentration at constant pump
energy. Mirroring a conventional threshold curve, the output
intensity was extremely sensitive to small changes in the probe
concentration when the pump energy was close to the associated
threshold point. For instance, from the model globally ﬁt to the
data, if the pump energy were ﬁxed at 1.001 × 1016 photons
pulse−1, which was the threshold point for 119.4 pmol mL−1 V1,
a 50% increase in the probe concentration from 100.0 pmol mL−1
to 150.0 pmol mL−1 would result in a 17,000 times increase in the
intensity. Away from the threshold point, a 50% change would
simply result in a ~50% change in the intensity, as is typical for a
ratiometric assay, which might be difﬁcult to see above the
background. This is the greatest responsivity in output intensity
to small changes in probe concentration that has been recorded in
any biological assay, as far as we know. The analytical concept has
immediate applications in tipping point measurements, where the
sample would be pumped at the threshold intensity for the critical
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Fig. 3 Quantiﬁcation of virus-lasing probes. a Response of the threshold
point to variations in probe concentration. Scatter points represent the
threshold point calculated by ﬁtting individual sets of threshold data of
either V1 (dark blue) or ﬂuorescein (dark orange) using equation (26). The
line is the expected dependence of the threshold point on the probe
concentration calculated from the global ﬁt in Fig. 2a. The error bars are
standard errors and the error bar that extends beyond the upper limit of the
y-axis extends to inﬁnity. b The intensity at different probe concentrations
has been plotted at pump energies of 1.0 × 1016 photons pulse−1 ± 5.7%
(dark blue), 5.4 × 1015 photons pulse−1 ± 7.6% (green), 1.8 × 1015 photons
pulse−1 ± 6.2% (purple), 1.4 × 1015 photons pulse−1 ± 5.3% (cyan), 5.5 ×
1014 photons pulse−1 ± 4.8% (light green), 2.5 × 1014 photons pulse−1 ±
6.3% (blue), 9.6 × 1013 photons pulse−1 ± 5.8 % (light purple). The lines are
simulations from the same global ﬁt for the intensity against probe
concentration at the same pump energies. Source data are provided as a
Source Data ﬁle
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concentration of lasing probes to yield an unambiguous, digital
readout: if there is lasing, then the critical concentration is
exceeded, otherwise there is no lasing. Alternatively, the pump
energy could be scanned to ﬁnd the threshold point, and
therefore the probe concentration, via cross-referencing with a
calibration plot such as Fig. 3a.
We conﬁrmed that the probe could still infect F pilus strains of
E. coli by performing a plaque titer assay which is a technique
used to estimate the concentration of infectious phage (details in
Methods). In this assay, the target molecules are the bacterial F
pilus and then the membrane protein TolA on the surface of E.
coli which the g3p protein must bind for the phage to infect the
cell.43 The titer assay yielded 1013 plaque-forming units mL−1
(Supplementary Table 1), substantiating that the dye-labelled
M13 remained infectious and therefore suggests that g3p was not
inhibited from binding its receptor by the covalent modiﬁcation
of the coat proteins with ﬂuorescein dye. Furthermore, dye-
labelled mutant M13 have been shown to retain their binding
selectively for granulocytes and monocytes in a g3p-based phage
display system in both ﬂow cytometry and immunoﬂuorescence
studies.31
As for other optical assays, control measurements prior to
the addition of the lasing detection probes can ﬁx the
contribution of noise sources and any other chromophores
in the sample. Beyond this, the potential for multiplexing
in virus lasers is intrinsically greater than for ﬂuorescence-
based techniques such as ﬂow cytometry because the emission
spectral linewidths are narrower, enabling the implementation
of companion probes to monitor changes in environmental
factors for even greater measurement precision. To do this,
we propose decomposing the overlapping gain spectra of
the different probes by sweeping the dispersive element in a
tunable virus laser to record the intensity at different emission
wavelengths. Future work will aim to quantify the multiplexing
capability of virus lasers, determine the impact of cellular
milieu and blood serum on lasing, and harness synthetic
biology to engineer environmentally insensitive probes.
Virus-laser mix-and-measure ligand-binding assay. Most assay
formats gain sensitivity by trading a degree of disruption to the
biological system, for instance, by immobilising the ligands or
probes and introducing wash steps, or by labelling the ligands.
Given the unprecedented signal-generation capabilities of virus-
lasing probes, we have tested the feasibility of a mix-and-measure
ligand-binding assay which does not necessitate these trade-offs.
Analogous to a plasmonic approach where ligand-binding to
antibodies immobilized on a metal surface modulates the optical
response,44 the aim was to measure shifts in the threshold point
and variations in the output intensity in response to solution-
phase binding of the lasing probes. For such an assay, the virus
laser needs to be sensitive to the binding of the probes to a target
ligand. Accordingly, we increased the impact of near-ﬁeld and
electronic interactions occurring at sub-1 ns timescales on the
surface of the phage by reducing the resonator (designated R2)
length to 26 mm, corresponding to a round-trip time of 195 ps
taking the refractive index of the gain medium into account
(Fig. 1b). We increased the effect of binding on a single probe by
increasing the density of dye molecules per probe, and reduced
the concentration of probes to less than Dmin for resonator R1.
This improvement in the sensitivity resulted from the reduction
in the resonator length, which increased KRAD; further perfor-
mance enhancements would result from extending this approach.
The number of spatial modes was constrained by introducing a
300 µm pinhole so that the Fresnel number of the resonator was
F ¼ 6:7.
For both 23 pmol mL−1 M13 conjugated with 564 dyes per
M13 (V2), equivalent to 1.0 dye on average per ring of coat
proteins, and 13 nmol mL−1 unbound ﬂuorescein dye molecules
in buffer (F2), threshold and spectral measurements were
acquired before and after (Fig. 4a, b, Supplementary Fig. 7 and
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Fig. 4 Response of the virus laser to ligand-binding. a Spectra of V2 before
(cyan) the addition of cp-mAb at 1.3 × 1016 photons pulse−1 and after (light
green) the addition of the antibody at 1.4 × 1016 photons pulse−1. Each
scatter point is the mean of four measurements at each wavelength and the
curves are ﬁts to the sum of two Voigt peak functions (dark blue) and a
Lorentzian peak function (green). b Threshold behaviour of V2 before and
after the addition of cp-mAb, same colours as (a). Lines represent
individual ﬁts of the data to equation (26). c Time-dependence of the
intensity at 523.5 nm at pump energies initially above threshold at 1.3 × 1016
photons pulse−1 ± 4.7% (purple) and below threshold at 1.6 × 1015 photons
pulse−1 ± 4.4% (green). The concentration of cp-mAb, which is a ligand
bound by M13, in the gain medium after mixing increases in steps from
0 fmol mL−1 to 9 fmol mL−1, 29 fmol mL−1 and then 90 fmol mL−1. The
arrows indicate when cp-mAb was added to the reservoir, and the lengths
of the arrows are proportional to the amount added to the reservoir at each
step. The squares and error bars represent the mean and standard
deviation, respectively, of 7 measurements taken at each point in the time
series. The variation in intensity at each time point is caused by small
ﬂuctuations in the pump energy and random variations in the response of
the intensity to pumping. See Supplementary Figs. 7, 8 and 9 for all of the
collected data. Source data are provided as a Source Data ﬁle
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Supplementary Fig. 8) the addition of a monoclonal antibody (cp-
mAb, illustrated in Fig. 1a) to the reservoir feeding the gain
medium, which is a ligand bound speciﬁcally by the ﬁve gene 3
coat proteins at one end of the phage. Between these measure-
ment sets, for V2 only, we collected intensity data at three
different levels of pumping 15 min after adding either a buffer
control or cp-mAb into the reservoir containing the detection
probes (Fig. 4c, Supplementary Fig. 9).
For V2, lasing could no longer be sustained with pump pulses
of 1.4 × 1016 photons pulse−1 after the addition of 90 fmol mL−1
cp-mAb to the gain medium, resulting in a 690-fold decrease in
the intensity at 524.8 nm (Fig. 4a). The cp-mAb was added to the
reservoir feeding the gain medium in three steps, so the intensity
data reveal the response of the virus laser to step increases in cp-
mAb. The addition of 9 fmol mL−1 cp-mAb to the gain medium
and then another 20 fmol mL−1 cp-mAb triggered an increase in
the threshold point of V2 as the antibody mixed and bound to the
surface of the lasing detection probes (Fig. 4c). The threshold
point reached a new steady-state position after ~70 min with no
subsequent addition of cp-mAb, but this was disturbed upon
addition of a further 61 fmol mL−1 cp-mAb, which coincided
with the cessation of lasing (Fig. 4c).
The initial 5.5-fold step-change at a pump level of 1.3 × 1016
photons pulse−1 was in response to 29 fmol mL−1 cp-mAb,
which equates to 780 lasing detection probes per 1 target
biomolecule, and when pumping was below-threshold the
addition of cp-mAb had no effect on the intensity, indicating
that lasing was crucial to the responsivity (Fig. 4c). The antibodies
bound to the phage would red-shift the absorption spectra of
certain dyes due to solvent exclusion and contact with a dielectric
body with polar side-chains:45,46 anti-ﬂuorescein fab fragments
bound to ﬂuorescein shift the absorption peak from 491 nm to the
ranges 505 nm to 507 nm and/or 518 nm to 520 nm with
ﬂuorescence quenching maxima values of 95% to 97%.47
Theoretical studies of 5 µMmL−1 donor dye in bulk solution
doped with 0.1 µMmL−1 acceptor dye suggest that these red-
shifted dyes would sink energy by cavity-enhanced energy
transfer and FRET, increasing the threshold point.48 This effect
would be enhanced by homo-FRET transfer between dyes on the
same phage,49 and absorption of the emission by ground-state
dyes on the antibody-bound phage. Our experiment provides the
ﬁrst empirical evidence that a biolaser can detect a medically-
relevant class of biomolecule at clinically relevant concentrations
below the probe concentration.
Since the fraction of ligands bound by probes initially increases
at a rate determined by the probe concentration and the on rate,
which is typically ~105 M−1 s−1 for an antibody,50 mix-and-
measure ligand-binding assays with a large excess of probes could
rapidly detect sub-1 fmol mL−1 ligand concentrations, which is
often not practical for nanosensors or surface-based methods due
to long accumulation times.51 The characteristic timescale for
shifts in the threshold point at a probe concentration of 23 pmol
mL−1 would be 7.2 min if the on rate were ~105 M−1 s−1 50 so
the effect of target-binding could be readily distinguished from
effects that would cause an immediate shift in the threshold point,
including changes in the optical density of the gain medium or
the quality factor of the resonant cavity.
ELISA, which involves binding the ligands to surface-
immobilized antibodies before adding a large excess of a second
antibody which binds a different epitope of the surface-bound
ligands, can achieve detection limits between 1 pmol mL−1 and
0.1 amol mL−1 depending on the antibody-antigen afﬁnity,52 but
unbound probes must be washed away making this technique
laborious, disruptive to the biological system and unsuited to
continuous monitoring applications. Here, sources of systematic
error could be mitigated using strategies analogous to those
accepted as best-practice for surface-plasmon-resonance ligand-
binding assays. For example, a differential measurement could be
set up by adding the biological sample to matched solutions
containing different phage-clones with the same density of
ﬂuorescein per probe but with g3p coat proteins programmed to
either bind or not bind the target ligand. The accuracy would
depend on the precision with which the lasing threshold could be
measured, which would be very high given that this simply
involves measuring the photon ﬂux of the pump, and the
similarity of the initial lasing responses of the binding and non-
binding probe solutions. In the control experiment, F2 was only
marginally responsive to the addition of 9.1 pmol mL−1 cp-mAb,
showing that ﬂuorescein does not bind cp-mAb and that the
lasing performance is not inherently affected by the target
biomolecule or by any other molecules or salts in the solution
(Supplementary Fig. 7, Supplementary Fig. 8). Other explanations
for the observed change in the threshold dynamics, including
photobleaching, dilution of the probes due to the ﬁlter and the
addition of buffer, and air bubbles have been ruled out for reasons
explained in the Supplementary Discussion.
In two further experiments, photobleaching caused a steady
increase in the threshold point of the virus laser as time elapsed
without any step-changes, and in further experiment 1, there was
no response to the addition of a non-binding control antibody
(mouse IgG2a isotype control) (Fig. 5). In both experiments, the
subsequent addition of the cp-mAb ligand resulted in a step-
change in the threshold point conﬁrming the speciﬁcity of the
ligand-binding assay. The effect is more pronounced and
immediate in further experiment 2 than in further experiment
1, consistent with more cp-mAb being adding in further
experiment 2. See the Methods for more experimental details
and the Supplementary Discussion for further analysis.
If the gain were insufﬁcient to overcome the losses due to
absorption or scattering by non-target molecules, or if the losses
were too variable to accurately measure the threshold point, then
we could dilute the sample in a buffer solution as is common
practice in spectrophotometry. For instance, R2 could be used as a
process analytical technology for detecting antibodies in samples
extracted directly from an industrial bioreactor if the sample were
diluted 10,000-fold in the buffer reservoir feeding the gain
medium. If the cell culture had an optical density of 100 at the
emission wavelength, then the round-trip loss after dilution would
be 2% from the Beer–Lambert law, which would not prohibit
lasing. We have shown that R2 is sensitive to 29 fmol mL−1
cp-mAb so we estimate that ~300 pmol mL−1 IgG in an
industrial bioreactor could be detected using this approach.
For comparison, the mean of the central 95% range of the
age-corrected human serum IgG concentration distribution is
70 nmol mL−1.53
Discussion
Virus biolasers can deliver a ﬁve decade increase in signal, 4 nm
emission linewidths and large, non-linear responses in output
intensity to small changes in probe concentration. The optical
technologies required for lasing detection, including compact
pump lasers and photodetectors, could be readily integrated into
existing ﬂuorimeter platforms, making them into powerful tools
for digital biomedicine. Our proof-of-concept experiments sug-
gest that biolasers could measure clinically relevant concentra-
tions of biomolecules with a sensitivity approaching that of
ELISA, yet without the need for probe immobilization or multiple
wash steps. This paves the way for research, eventually employing
whole blood and urine with clinical applications in mind, to
genetically engineer a series of virus-lasing probes which selec-
tively bind target biomolecules directly in solution.
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Methods
Sample preparation. The M13 stock was prepared from a single plaque to ensure
genetic homogeneity. M13 was ampliﬁed in E. coli Top10F’ cultures and puriﬁed by
several rounds of centrifugation with or without 5% polyethylene glycol (PEG-
8000) and 0.2 M sodium chloride to either selectively precipitate the phage or to
remove cells and cellular debris. For the ﬁrst round of precipitation for the M13
prepared for experiments in R1, the concentration of precipitating agent was
reduced to 3.3% PEG-8000 and 130 mM NaCl. The M13 solutions were ﬁlter-
sterilised with a 0.22 µm ﬁlter. For the experiments performed in R1, 24.9 mg
ﬂuorescein isothiocyanate isomer 1 (FITC) powder was added to 50 mL
2.0 mgmL−1 M13, 100 mM sodium borate, pH 9.1, and incubated for 2 hr at 37 °C
prior to quenching with 20 mL 1M tris-HCl, pH 7.5. For the experiments per-
formed in R2, 15.5 mg FITC powder was added to 29.8 mL 0.7 mgmL−1 M13,
100 mM sodium borate, pH 9.2, and incubated for 4 h 15 min at 37 °C prior to
quenching with 90 mL 133 mM tris-HCl. In both procedures, the dye was removed
by rounds of centrifugation with and without PEG-8000/NaCl. The precipitated
M13 was resuspended in 100 mM sodium borate, pH 9.0. For the dye-labelled M13
used in R2, the solution was also driven through a 0.22 µm ﬁlter.
The M13-binding antibody (Life Technologies, M13 phage coat protein
monoclonal antibody from clone E1) which recognises the ﬁve g3p coat proteins
at one end of M13 and the non-binding antibody (Life Technologies, Mouse
IgG2a isotype control) were aliquoted and stored at –20 °C at a concentration of
1 mgmL−1. Before use, the antibody stock would be thawed prior to dilution to the
appropriate concentration. The antibody was added to the reservoir of the gain
medium by pipetting the antibody onto the side-wall of the reservoir and washing
the side-wall with the sample ejected from the silicone tubing connected to the ﬂow
cuvette. The antibody was allowed to mix with the sample solution as it circulated
between the reservoir and the ﬂow cuvette prior to measurement for 15 min for V2
and for 20 min for F2 (Fig. 4, Supplementary Figs. 7–9). The buffer control was
added in the same way. The molecular mass of the M13-binding antibody was
assumed to be approximately 160 kDa.
M13 titer assay. Dye-labelled M13 was serially diluted and 10 μL drops of each
dilution were spotted onto bacterial lawns, which were prepared by pouring 4 mL
of a mix of 0.7% Nutrient Broth No. 2 agar and E. coli Top10F’ culture onto thin
base 1.5% Nutrient Broth No. 2 agar plates. The mix contained 20 mL E.
coli Top10F’ culture grown overnight in Nutrient Broth No. 2 per 200 mL 0.7%
Nutrient Broth No. 2 agar. After spotting the dye-labelled M13 dilutions, plates
were incubated overnight at 37 °C. The phage titer was calculated from the number
of plaques, the dilution factor and the sample volume.
Free-space optical assembly. The resonant cavities were pumped with pulses of
493 nm light with a FWHM (Full Width at Half Maximum) of 3 ns to 5 ns from an
optical parametric oscillator (EKSPLA, NT 342B-20-AW) in single-shot mode via
beam-shaping optics consisting of spherical (Comar Optics, 200 PB 25 and 100 NB
25) and cylindrical (Comar Optics, 100 YB 40 and 25 UB 25) BK7 crown-glass
lenses with anti-reﬂection coatings, which transformed the 4.5 mm diameter cir-
cular beam cross-section to a 2 mm × 9mm ellipse (Supplementary Fig. 1). The
pulse intensity was controlled with two Glan-Laser calcite polarizers (Thorlabs,
GL10). The ﬁrst was mounted in a motorised rotation stage (Thorlabs, PRM1/
MZ8) connected to a T-cube DC servo controller (Thorlabs, TDC001) and the
second was ﬁxed with its polarization axis parallel to the polarization of the
excitation pulses. The pump energy was monitored by partially reﬂecting the light
with either, in R1, a pellicle beamsplitter (Thorlabs, BP208), or, in R2, a glass
window, towards a pyroelectric probe (Molectron, J25) connected to a Joulemeter
(Molectron, EM500). In R2, a plano-concave, f=−50 mm lens (Newport,
KPC040) was placed before the pyroelectric probe to match the widths of the beam
and the sensor. In R1, the detector electronics was triggered by the electronic
trigger from the pump source; in R2 it was triggered by an optical trigger, con-
sisting of a photodiode (Thorlabs, SM1PD1A) connected to a high-speed circuit
preceded by an OD 2 neutral density ﬁlter (Thorlabs, NDUV20B) with minor
damage to the optical coating, positioned behind a protected aluminum mirror
(Thorlabs, PF10-03-G01) in the path between the beamsplitting window and the
pyroelectric probe. Additionally, for R2, the pump was transmitted through a
rectangular aperture that matched the dimensions of the cuvette window, and a
dielectric shortpass ﬁlter with a cut-off wavelength of 510 nm (Comar Optics, 510
IK 50).
The pump impinged on a 2 mm × 8mm window to a ﬂow cuvette (Starna,
583.2.2FQ-10/Z15) with a 2 mm × 2mm × 10 mm internal chamber, so the
maximum path length of the pump light through the cuvette was 2 mm since the
long axis of the internal chamber was orthogonal to the direction of the pump
beam and parallel to the axis of the resonant cavity. The samples or cleaning ﬂuids
were ﬂowed into the cuvette via silicone tubing from reservoirs using a peristaltic
pump (RS Components), and samples would then ﬂow back into the reservoir. The
ﬂow rates were 2.5 mLmin−1 for R1 and 3.0 mLmin−1 for R2, and the time
between pulses was long enough for the dye in the cuvette to be refreshed. For R2,
there was a 5 µm in-line ﬁlter (Whatman, Polydisc HD 5.0 µm) between the
reservoir and the cuvette. In further experiment 2 in R2, the in-line ﬁlter was
removed and the ﬂow rate was increased to 4 mLmin−1. The cuvette had 2 mm ×
2mm Spectrosil quartz windows on opposing walls at 90° to the entrance window,
which were aligned with the axis of the resonant cavity. The Fresnel reﬂectance at
the glass interface would have been,
r ¼ n1  n2
n1 þ n2
 2
ð3Þ
so that r ¼ 0:0350 at the glass-air interface for n fused  silicað Þ ¼ 1:46 and
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Fig. 5 Step-changes in the threshold point in response to ligand-binding. In two further experiments in R2, the threshold behaviour of dye-labelled M13 was
monitored as a function of time and the addition of cp-mAb or a non-binding antibody. For each experiment, the data were ﬁt globally using equation (26)
with parameters χ0 and χ1 shared between each set of threshold measurements. For further experiment 2, 20 pmol mL−1 V2 contained no antibody (blue),
before 4.5 pmol mL−1 cp-mAb was added (green). For further experiment 1, 23 pmol mL−1 V2 initially contained no antibody (blue), 91 fmol mL−1 mouse
IgG2a isotype control was added (black) and then cp-mAb was added in two steps so that the concentration of cp-mAb was initially 91 fmol mL−1 (purple)
and then increased to 1.9 pmol mL−1 (green). See Methods for more details. The threshold points derived from the ﬁtted models have been plotted against
time for, a further experiment 2 and for, b further experiment 1. Measurements have been represented by an arrow if the ﬁtting implied that the sample
could no longer sustain lasing. The error bars represent standard errors and the error bars that extend beyond the upper limit of the y-axis extend to
inﬁnity. See Supplementary Fig. 10 for an expanded version of this ﬁgure with the intensity against pump energy data for different points in the time series.
Source data are provided as a Source Data ﬁle
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n airð Þ ¼ 1:00, and r ¼ 0:00217 at the glass-water interface for n waterð Þ ¼ 1:33.
Consequently, the transmission through the cuvette was nominally 0.860 per
round-trip of the resonant cavity.
R1 consisted of a ﬂat dielectric output coupler (Comar Optics, 25 MX 02) and a
dielectric spherical mirror with a radius of curvature of 400 mm (Thorlabs,
CM508-200-E02), separated by 300 mm with the cuvette adjacent to the output
coupler. In R2, the spherical mirror was replaced with a compound optic consisting
of a protected silver spherical mirror with a radius of curvature of 50 mm
(Thorlabs, CM254-025-P01) bonded to a 300 µm pinhole (Thorlabs, P300S) and
the separation of the mirrors was reduced to 26 mm. The reﬂectivity of the ﬂat
mirror was 99% and the reﬂectivities of the dielectric and metallic spherical mirrors
were 99.6% at 530 nm unpolarized and 98.8% at 520 nm unpolarized, respectively,
based on product data from the manufacturers. The fraction of the oscillation
retained was then nominally 0.848 per round-trip for R1, and 0.841 per round-trip
for R2. The round-trip time for light oscillating between the mirrors of the resonant
cavities was 2.0 ns for R1 and 195 ps for R2, for a cuvette ﬁlled with water. The
diameters of the mirrors were much greater than the diameters of the cuvette
windows and the pinhole, so the Fresnel number
F ¼ a
2
L λ
ð4Þ
where a is the radius of the aperture and L is the length of the resonant cavity, was
approximately 1 mmð Þ
2
300 mm ´ 530 nm ¼ 6:3 for R1 and 0:3 mmð Þ
2
26 mm ´ 520 nm ¼ 6:7 for R2. In both
cases, F > 1 so large diffraction losses are not anticipated.
The effective volume of the gain medium is the volume that is pumped which
can contribute to the laser emission. For R1, this is the entire volume of the cuvette
chamber that is subjected to pumping, Veff ¼ 8 mm ´ 2 mm ´ 2 mm ¼ 32 μL.
For R2, this volume is reduced due to the pinhole before the spherical mirror. R2
has a half-confocal resonator geometry, so the radius of the beam at the ﬂat mirror
is expected to be a factor of  1ﬃﬃ
2
p of the radius at the spherical mirror, which is
r  150 μm due to the pinhole. Using similar cones, the effective volume of the
gain medium Veff that is pumped is given by,
Veff ¼
π
6
r
L
 2 ﬃﬃ
2
p
 1
 2 Lﬃﬃ
2
p  1þ l2
 3
 Lﬃﬃ
2
p  1þ l1
 3( )
ð5Þ
where l1 is the separation of the ﬂat mirror and the closest edge of the pumped
volume, and l2 is the separation of the ﬂat mirror and the furthest edge of the
pumped volume. For l1  4:5 mm, l2  12:5 mm and L  26 mm,
Veff R2ð Þ  0:365 μL.
The absorption of the pump by the gain medium depends on the optical path
length of the gain medium in the direction of the pump. For R2, the mean optical
path length lmean can be estimated by calculating the mean path length across a
cylinder with the same length and volume as the effective volume of the gain
medium, so
lmean ¼
4
π
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Veff
π l2  l1ð Þ
s
ð6Þ
For R2, lmean  153 μm. For R1, lmean ¼ 2 mm, which is the depth of the cuvette
chamber.
We collected the light transmitted through the output coupler with either an
unoccluded lens (Newport, KPX112) or a lens coupled with an iris diaphragm
(Thorlabs, LA1484-A, and Thorlabs, SM1D12CZ) such that the f/numbers were
300 mm=22:9 mm ¼ 13:1 for R1 and 300 mm=5:5 mm ¼ 54:5 for R2,
respectively. A custom-built spectrometer combining a photomultiplier tube
(PMT) (Hamamatsu Photonics, R1166) connected to a high voltage supply
(Hamamatsu Photonics, C9525) and a Czerny-Turner monochromator (Bentham,
M300EA) with a focal length of 300 mm, f/number of 4.2 and a 1200 grooves
mm−1 grating, recorded the output intensity. Before the spectrometer, the intensity
could be optically attenuated using UV fused-silica reﬂective neutral density ﬁlters
with ODs ranging from 0.5 to 3.0 for R1 and 0.5 to 4.0 for R2 (Thorlabs) mounted
in a ﬁlter wheel working in conjunction with a OD 4.0 ﬁlter in a ﬂip mount. Optical
feedback was prevented by aligning the ﬂip mount for R1 and R2 and the ﬁlter
wheel for R2 so that the normal to each ﬁlter was not parallel to the direction of the
incident light. For R1 the mounts were manual but for R2 they were replaced with
motorised equivalents (Thorlabs, FW102C, and Thorlabs, MFF102/M). For R2,
optomechanics prevented stray light from entering the spectrometer, and a
dielectric longpass ﬁlter with a 500 nm cut-on (Thorlabs, FEL0500) connected to
the light-collecting lens blocked any scattered pump light. For R2, the bias voltage
to the PMT was –860 V because this enabled single-photon measurements without
compromising linearity.
The voltage across a 50Ω terminator (for R2, Pico Technology, TA051)
connected to the PMT was recorded using an oscilloscope (for R1, Tektronix,
TDS210 and for R2, Tektronix, TDS3052). The waveforms were transferred to a PC
for real-time analysis in a custom program that controlled the optical assembly
(National Instruments, LabVIEW 8).
The term “pump” refers to the radiant energy input into the resonant cavities
in units of photons pulse−1, which can be converted to a spectral irradiance of
the resonant cavities via multiplication by ħω (16 mm2)−1 (δλ(0.12 nm))−1
(4 ns pulse)−1, since the area of the cuvette window was 16 mm2, the spectral
linewidth of the optical parametric oscillator was 0.12 nm and the optical pulse
length was 3 ns to 5 ns, and ħω is the energy of one photon with a wavelength of
493 nm. The term “intensity” refers to the radiant energy emitted from the
resonant cavities in the direction of the detection optics per pulse. The reported
intensity is different to the signal observed by the detector by a factor that
accounts for the optical attenuation of the spectrometer, and does not account
for the radiation that emits in directions that bypass the spectrometer. The
oscillation build-up in the resonant cavity would have been greater than the
measured intensity. The output intensity from R2 was calibrated by measuring
the response of the detection electronics to single photons, so it is reported in
units of photons pulse−1. Equivalently, the output intensity from R2 can be
converted to a spectral intensity emitted from the resonant cavity with units ħω
(1.3 × 10−3 sr)−1 (δλ(0.4 nm))−1 pulse−1, where the solid angle of the
spectrometer is 1.3 × 10−3 sr and the linewidth of the monochromator is
approximately 0.4 nm, and ħω is the energy of one photon at the selected
wavelength of the monochromator. For R2, optomechanics and a ﬁlter prevented
light from external sources to the resonant cavity from entering the spectrometer
(more details in “Free-space optical assembly”), but this was not implemented
for R1. Consequently, R1 could not be calibrated by measuring the response of
the detection electronics to single photons. Instead, the intensity has been
reported in arbitrary units proportional to the number of photons emitted from
the resonant cavity in the direction of the detection optics per pulse.
Description of further experiments in R2. Two additional experiments were
performed in R2 using the same dye-labelled M13 sample to test whether
photobleaching could cause the step-changes in the intensity observed in
Fig. 4 (Fig. 5, Supplementary Fig. 7 and 10). Further experiment 1 was similar to
the experiment described in Results, except that 91 fmol mL−1 mouse IgG2a
isotype control, which should not be bound by M13, was added to the gain
medium before 91 fmol mL−1 cp-mAb was added, which was then increased to
1.9 pmol mL−1. Buffer was not added to the reservoir between measurements
and the antibody was allowed to mix for at least 12 min prior to measurement.
Further experiment 2 was similar to the previous experiments, except that the
dye-labelled M13 was diluted by a factor of ~0.89 in type 1 water and the ﬁnal
sample volume was ~2.75 mL, which was less than the 6.85 mL used in previous
experiments, and the in-line ﬁlter was removed. Also, prolonged storage of the
dye-labelled M13 at 4 °C resulted in some sedimentation, so the solution was
transferred to a fresh container and then centrifuged to remove any residual
insoluble material. For this experiment, only 4.5 pmol mL−1 cp-mAb was added.
The changes in the threshold dynamics with time before and after the addition of
antibody were measured in both experiments. Emission spectra before and after
the addition of antibody were acquired for further experiment 2 but not for
further experiment 1.
Characterisation of laser properties. The threshold dynamics were recorded by
measuring the output intensity at a ﬁxed wavelength at variable pump levels. The
intensity of the pump pulses were controlled by rotating the ﬁrst polarizer. If the
intensity was outside of the linear range of the spectrometer, the optical attenuation
was adjusted to compensate and the measurement was repeated. In R1, the
wavelength was ﬁxed to 527.0 nm and 528.0 nm for the measurements of ﬂuor-
escein and dye-labelled M13, respectively. In R2, the wavelength was ﬁxed to 520.5
nm and 523.5 nm for the measurements of ﬂuorescein and dye-labelled M13,
respectively, except for further experiment 2, for which the wavelength was ﬁxed to
525.0 nm.
The spectral measurements were acquired by ﬁxing the pump level and
recording the intensity at different emission wavelengths by rotating the
monochromator grating.
Characterisation of optical properties. The absorption spectra were recorded
using a UV-Vis spectrophotometer (for experiments using R1, Hitachi, Digilab
U-1800; for experiments using R2, Thermo Scientiﬁc, Nanodrop 2000C) with 1 cm
path length cuvettes.
The mass of a single M13 is taken to be 16.4 MDa ± 0.6 MDa (error is
2 standard deviations from the mean) which is the reported mass of fd virus based
on measurements of the translational diffusion coefﬁcient, sedimentation
coefﬁcient and density increment.28 The extinction coefﬁcient of M13 is taken to be
3.84 ± 0.06 mg−1 cm2 at 269 nm (error is 95% conﬁdence limit) which is the
reported extinction coefﬁcient of fd virus in KCl/P buffer.54 Based on these values,
the extinction coefﬁcient used to determine the concentration of M13 was 6.30 ×
107M−1 cm−1 at 269 nm.
The absorption of both the M13 and the ﬂuorescein at both the dye peak and at
269 nm were accounted for in the calculations of the concentration of dye-labelled
M13 and the number of attached dyes (Supplementary Fig. 2). The precision of the
stated concentrations was limited by the precision of the pipettes used (Gilson,
Pipetman) and the precision of the UV-Vis spectrophotometers.
For samples measured in R2, the extinction coefﬁcient of 34.0 µg mL−1
ﬂuorescein, 100 mM sodium borate, pH 9.0 was calculated to be 82752M−1 cm−1
at the peak absorption at 490 nm and 977M−1 cm−1 at 269 nm; the extinction
coefﬁcient of M13 at the absorption peak for the attached dyes at 494 nm was
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1.3 × 106 M−1 cm−1 (Supplementary Fig. 2). The extinction coefﬁcients of
ﬂuorescein attached to M13 were assumed to be the same as for unattached
ﬂuorescein at 269 nm and at the absorption peak. The concentration of the dyes
attached to the dye-labelled M13 was 12.8 nmol mL−1 and the concentration of
dye-labelled M13 was 23 pmol mL−1, so there were 564 dyes per M13 on average.
The ﬂuorescein was diluted by a factor of 0.13 before further measurements were
acquired, so its ﬁnal concentration was 13.3 nmol mL−1.
For samples measured in R1, the extinction coefﬁcient of 100 µg mL−1
ﬂuorescein, 100 mM sodium borate, pH 9.0 was calculated to be 82413M−1 cm−1
at the peak absorption at 491 nm and 10634M−1 cm−1 at 269 nm; the extinction
coefﬁcient of M13 at the absorption peak for the attached dyes at 493 nm was
determined to be 1.4 × 106 M−1 cm−1 (Supplementary Fig. 2). The concentration of
the dyes attached to the dye-labelled M13 was calculated to be 159 nmol mL−1
and the initial concentration of dye-labelled M13 was 413 pmol mL−1, so there
were 386 dyes per M13 on average. The initial concentration of ﬂuorescein was
301 nmol mL−1.
For both R1 and R2, the wavelength of the pump was 493 nm. For R1, the
extinction coefﬁcients at 493 nm compared to the extinction coefﬁcient at the
absorption peaks were a factor of 0.976 and 1 for ﬂuorescein and dye-labelled M13,
respectively. For R2 these factors were 0.984 and 0.991, respectively.
The separation of ﬂuorescein dyes in solution was calculated by taking the cube
root of the mean volume per dye.
Theoretical models. The changes in the energy build-up in a resonator mode and
in the upper state population of the dyes can be modelled using the two rate
equations:
dn
dt
¼ KRADD2 nþ n0ð Þ þ KRADD2  KLn ð7Þ
dD2
dt
¼ KFφ D D2ð Þ  KRADD2 nþ n0ð Þ  K2D2 ð8Þ
where n is the energy in the resonator mode, φ is the rate of pumping of the
resonator mode, D is the number of dyes in the resonator mode volume, D1 and D2
are the number of dyes in the lower and upper state of the laser transition,
respectively, KF is the strength of the coupling of the pump with the dyes, KRAD is
the rate of emission into the mode per dye, K2 is the rate of decay from the upper
state per dye, KL is the rate of loss from the resonator and n0 is the seed
ﬂuorescence.
In equation (7), the ﬁrst and second term describe the rate of stimulated and
spontaneous emission, and the third term describes the rate of loss from the
resonator. In equation (8), the ﬁrst term describes the rate of pumping of the dyes,
and the second and third terms describe the depopulation of the upper state due to
stimulated emission and all other sources, respectively.
The rate of pumping is derived from the Beer–Lambert law assuming that every
pump photon absorbed results in a dye in the upper state:
dD2
dt
¼ φ 1 eD1v ε l
 
 φ D1
ε l
v
¼ KFφ D D2ð Þ ð9Þ
where ε is the extinction coefﬁcient multiplied by ln(10), l is the optical depth of the
resonator mode and v is the volume of the resonator mode that is being pumped.
This approximation is valid for R2 because the concentration of the dyes was low
and the path length across the resonant cavity mode was narrow. For R1, these
assumptions do not strictly hold, but are necessary to simplify the equations so that
they can be solved analytically. Additionally, the Beer–Lambert law assumes that
the dyes are homogeneously distributed in the solution, which was not the case for
gain media composed of dye-labelled M13.
A full description of the threshold dynamics would require a rate equation for
the energy build-up in each resonator mode, but consideration of just a single
mode is sufﬁcient to model the key aspects of the system.55 Consistent with this
approach, the volume of the resonator mode being pumped v is set equal to the
effective volume of the gain medium being pumped Veff.
The rate of radiative emission per dye into the resonator mode is a function of
the rate of spontaneous emission and the number of resonator modes:
KRAD ¼
γRAD
ρ
ð10Þ
where γRAD is the rate of spontaneous emission per dye and ρ is the number of
resonator modes.
The rate of decay from the upper state per dye is the sum of the rate of
spontaneous emission and the rate of non-radiative decay:
K2 ¼ γRAD þ γNON ð11Þ
where γNON is the rate of non-radiative decay per dye.
KL is determined by the loss rate of the resonator, which is given by
KL ¼ 
1
τr
lnð1 LOSSÞ ð12Þ
where τr is the round-trip time and LOSS is the fraction of the oscillation build-up
lost per round-trip.
The energy in the resonator mode is derived from equation (7) and equation (8)
by assuming steady-state emission, eliminating D2 and solving the resulting
quadratic equation:
n ¼ β
2 KRAD
KF φ
D KRAD
KL
 1
 
 KRADn0  K2

þ
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KF φ
D KRAD
KL
 1
 
 KRAD n0  K2
 2
þ 4 KFφ D K
2
RAD
KL
n0 þ 1ð Þ
s 9=
;
ð13Þ
where β is the optical attenuation due to the output coupler and the spectral
bandwidth of the spectrometer.
The build-up of energy in the dominant resonator mode depends on optical
ampliﬁcation, which implies the presence of a non-zero seed ﬂuorescence n0 prior
to ampliﬁcation. This is modelled as the energy in the resonator mode when there
is no stimulated emission. From equation (7) and equation (8):
dn0
dt
¼ θ γRAD D2  KL n0 ð14Þ
dD2
dt
¼ KF φ D D2ð Þ  K2 D2 ð15Þ
where θ is the fraction of the spontaneous emission that emits at a wavelength and
in a direction such that it can contribute to the seed ﬂuorescence. Using the same
assumptions as for equation (13):
n0 ¼
D θ γRAD
KL 1þ K2KF φ
  ð16Þ
Light may have entered the spectrometer from external sources to the resonant
cavity, which is accounted for by a constant offset.
The threshold point φth is given by
KF φth
D KRAD
KL
 1
 
 KRAD n0  K2 ¼ 0 ð17Þ
from equation(13). Including the term for the seed ﬂuorescence, this is then
KF φth
D KRAD
KL
 1
 
 KRAD
D θ γRAD
KL 1þ K2KF φth
  K2 ¼ 0 ð18Þ
which can be solved to ﬁnd
φth ¼
K2 2KL  D KRADð Þ þ D KRAD θ γRAD þ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
θ γRAD  K2
 	2þ 4 θ γRAD K2 KLD KRAD
qn o
2 KF D KRAD  KLð Þ
ð19Þ
From equation (11), this can be simpliﬁed by noting that
θ γRAD  K2 ¼ γRAD þ γNON ð20Þ
Since
θ 1 ð21Þ
and that for gain to exceed losses
D KRAD
KL
>1 ð22Þ
so that the threshold point is given by
φth ¼
K2 KL
KF D KRAD  KLð Þ
ð1Þ
The minimum number of dyes required to achieve threshold Dmin even at very
large levels of pumping, is given by,
DMIN ¼
KL
KRAD
ð23Þ
From equation (13), the output energy far above threshold when φ!1 is given
by
n
φ
! β KF
KRAD
D KRAD
KL
 1
 
ð2Þ
Furthermore, if D Dmin, then
n
φ
! β KF D
KL
ð24Þ
and the gain above threshold ceases to depend on the rate of spontaneous emission.
The time-dependence of the pump energy was accounted for by assuming a
Gaussian proﬁle with a FWHM of 4 ns,
φðtÞ ¼ φ0 ´ GaussianðtÞ ð25Þ
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and calculating the output energy based on the peak pump energy. The non-linear
response of output energy to increased pumping means that the peak pump energy
has the greatest contribution to the overall output energy. An alternative method
was tested in which the pump pulse was split into sub-nanosecond time bins over a
~50 ns time window centred about the pulse peak and the output energy calculated
by summing the output energies from each time bin, but the results generated were
negligibly different to the preferred method. The calculation of the threshold point
accounted for the time-dependence of the pump energy.
For R2, only l2 mm of the pump impinged on the resonator mode because its
diameter was less than the 2 mm height of the window. The remainder would have
pumped dyes outside of the dominant resonator mode.
The threshold point for each threshold measurement could be readily
determined using a model similar to equation (13),
n ¼ χ0 þ χ1
φ
φth
 1
 
þ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
φ
φth
 1
 2
þχ2φ
s8<
:
9=
; ð26Þ
where χn are ﬁt parameters that are not directly linked to the experimentally
observable variables, φth is the threshold point and the time-dependence of the
pump is disregarded.
Data analysis. For R1, the threshold dynamics of ﬂuorescein and dye-labelled M13
were analysed by globally ﬁtting each set of data with a model that employed
equation (13) as well as equation (16) for the seed ﬂuorescence (Fig. 2a, Supple-
mentary Fig. 5). The parameters γRAD, KL, KF, lmean, and Veff were all ﬁxed and the
same for each set of measurements. Each of these were calculated in advance (see
Methods sections “Free-space optical assembly” and “Theoretical models”), except
for γRAD which is known to equal 0.240 ns−1.56 D was ﬁxed but different for each
set of measurements. A factor was calculated from the spectral measurements to
account for the difference between the intensity at the measured emission wave-
length and the spectral peak, which was ﬁxed for each set of measurements except
for 146 nmol mL−1 ﬂuorescein, since there was no spectral measurement of this
sample and it may have undergone a spectral shift. The parameters ρ, β, θ and a
constant offset to account for external light sources were not ﬁxed and were shared
between each set of data because they should be consistent between measurements.
The parameter γNON was not ﬁxed and shared between the sets of dye-labelled M13
measurements, but allowed to vary individually for each set of ﬂuorescein
measurements.
In Fig. 3a, the line representing the threshold point as a function of probe
concentration was simulated using this model. In Fig. 3b, the pump energy values
were selected because they represent local minima in a plot of pulse energy
variability against pulse energy. The pulse energy varies from pulse to pulse due to
variability in the intensity of the emission from the optical parametric oscillator.
The lines were simulated using the same model.
For R1, the threshold measurements were additionally ﬁt using equation(26) to
accurately determine the position of the threshold point (Fig. 3a, Supplementary
Fig. 6). From equation(1), as D! DMIN, φth !1 and if D<DMIN then φth<0, so
the parameter φth was substituted for its reciprocal in the ﬁtting function and
subsequently derived after the model converged. φth<0 for the most dilute dye-
labelled M13 sample, implying that the probe concentration was insufﬁcient to
achieve lasing.
For R2, the threshold measurements were individually ﬁt using equation (26)
(Fig. 4b, Supplementary Fig. 8). For the further experiments in R2, the threshold
measurements were also ﬁt using equation (26), but parameters χ1 and χ2 were
shared between sets of data from the same experiment (Fig. 5, Supplementary
Fig. 10). From comparison of the parameters in equation (26) and equation (13)
with zero seed ﬂuorescence, we expected χ1 and χ2 to be consistent between these
measurements.
For R1, when the pumping was above the threshold for lasing, the spectra
were ﬁt to a model consisting of a sum of two Gaussian functions with a constant
offset (Fig. 2b and inset, Supplementary Fig. 4). For R2, the above-threshold
spectra were ﬁt to a model consisting of a single Voigt function or a sum of two
Voigt functions with no constant offset, and the below-threshold spectra were ﬁt
to a Lorentzian function with no constant offset. In Fig. 4, the scatter points in
the spectra are the means of four measurements at each wavelength; see
Supplementary Fig. 7 for the same data presented without averaging. The mean
and coefﬁcient of variation of the pump energy has been reported for each
emission spectrum (Supplementary Fig. 4, Supplementary Fig. 7). The spectral
peak centres and linewidths were determined by the model ﬁtting and the
reported errors are standard errors.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Source data are provided as a Source Data ﬁle. The source data are also available for
download from UCL’s open-access repository, UCL Discovery [http://discovery.ucl.ac.uk/].
Code availability
The custom computer code for the ﬁtting functions used for the data analysis is provided
as a Computer Code ﬁle. The computer code is also available for download from UCL’s
open-access repository, UCL Discovery [http://discovery.ucl.ac.uk/].
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